Sterling Pharma Solutions
Joseph Culloty is an experienced quality management professional with a robust background in the pharmaceutical industry. Currently serving as Head of Quality at Sterling Pharma Solutions since January 2023, Joseph previously held various roles at Novartis from November 2012 to January 2023, including Head of Quality, QA Facilitator, Product Steward, and Process Manager. Prior experience at Corden PharmaChem involved R&D and production chemistry, where Joseph successfully scaled up numerous laboratory processes and completed a tech transfer to an overseas sister company. An early career placement at Pfizer provided foundational experience in chemical services. Joseph holds a Master's degree in Strategic Quality Management from the University of Limerick and a BSc in Chemistry of Pharmaceutical Compounds from University College Cork.
This person is not in any teams
This person is not in any offices
Sterling Pharma Solutions
1 followers
Sterling Pharma Solutions has over 50 years' experience serving the global pharmaceutical industry. Our facilities are located in Cramlington and Newcastle Biosphere, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Our state-of-the-art facilities, proprietary technologies and experienced people are among the best in the industry. We have a proven track record in the supply of chemistry and analytical services across the entire product lifecycle, from grams to tonnes, from pre-clinical to commercial supply. Our world-class safety and quality standards are globally recognised and demonstrated through successful MHRA and FDA inspections and CIA Gold Awards for Safety the last three consecutive years. We pride ourselves on our customer focus and service approach, offering flexible, tailored solutions to our customers. In addition, our North Carolina and Newcastle Biosphere facilities offer expert chemistry solutions for small volume batches or products in the early stages of clinical trials. Our Deeside, Wales facility provide bioconjugation development services and specialised in antibody drug conjugation (ADC) research and development. Find out more: www.sterlingpharmasolutions.com/sterling-facilities